Orizuru Therapeutics

Developer of stem-cell-derived organoid models for drug discovery

placeKyoto, Kyoto, Japan calendar_todayFounded 2021 groups60 employees language orizuru-therapeutics.com

Registered entities

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon